INNATE PHARMA: cash_and_equivalents
| Value | {"amount": 152314000.0, "concept": "ifrs-full:CashAndCashEquivalents"} |
|---|---|
| Period | (as of 2018-12-31) |
| Status | current |
| Entity | INNATE PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T01:52:01.406755+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/0dbc5df6-224a-4636-9cec-c6e6b7e036e1
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:9695002Y8420ZB8HJE29:2020-12-31Retrieved: 2026-08-24T01:52:01.406755+02:00
Raw response sha256:
354f3f3237e82bfb1dcf2f5d47f77cbb…Cite as: FACTANKER, https://factanker.com/fact/0dbc5df6-224a-4636-9cec-c6e6b7e036e1
History
- no predecessors — first report